CD19 and congenital rubella syndrome: Toxicities commonly associated with anti‐CD19 CAR‐T were relatively low with any grade and severe CRS in 47.5% and 5.1%, respectively, and any grade and severe neurotoxicity in 20.3% and 5.1%, respectively.